Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
[Symptoms and neurological findings in patients with multiple sclerosis].
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
Autoimmune neuropathies: insights from animal models.
Different cortical underpinnings for fatigue and depression in MS?
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Ethanol-Induced TLR4/NLRP3 Neuroinflammatory Response in Microglial Cells Promotes Leukocyte Infiltration Across the BBB.
Self-esteem, social participation, and quality of life in patients with multiple sclerosis.
Kainic Acid-Induced Excitotoxicity Experimental Model: Protective Merits of Natural Products and Plant Extracts.
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited.
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Conformational Changes and Association of Membrane-Interacting Peptides in Myelin Membrane Models: A Case of the C-Terminal Peptide of Proteolipid Protein and the Antimicrobial Peptide Melittin.
The experiences of support persons of people newly diagnosed with multiple sclerosis: an interpretative phenomenological study.
Is there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?

Pages